Showing results (31-40 of 71) with videos related to
Sort By:
Pageof 8
Haematologica|August 21, 2020
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Guérin infectionFrancesca Tucci, Vera Gallo, Federica Barzaghi, et al.Blood Advances|August 23, 2021
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiencyMatteo Zoccolillo, Immacolata Brigida, Federica Barzaghi, et al.The Journal of Allergy and Clinical Immunology. in Practice|August 5, 2019
Rituximab Unveils Hypogammaglobulinemia and Immunodeficiency in Children with Autoimmune CytopeniaGiorgio Ottaviano, Maddalena Marinoni, Simona Graziani, et al.Blood|May 1, 2016
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiencyMaria Pia Cicalese, Francesca Ferrua, Laura Castagnaro, et al.Journal of Clinical Immunology|August 9, 2022
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous DiseaseMaddalena Migliavacca, Luca Basso Ricci, Giada Farinelli, et al.The Journal of Allergy and Clinical Immunology|September 7, 2023
Impact of newborn screening for SCID on the management of congenital athymiaEvey Howley, Zainab Golwala, Matthew Buckland, et al.The Journal of Allergy and Clinical Immunology|December 2, 2024
Consensus of the Italian Primary Immunodeficiency Network on the use and interpretation of genetic testing for diagnosing inborn errors of immunityGiuliana Giardino, Gigliola Di Matteo, Silvia Giliani, et al.Scientific Reports|January 12, 2017
Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patientsAisha V Sauer, Raisa Jofra Hernandez, Francesca Fumagalli, et al.The Journal of Allergy and Clinical Immunology|September 24, 2022
Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutationMansi Narula, Uma Lakshmanan, Simon Borna, et al.Molecular Therapy. Methods & Clinical Development|December 1, 2025
Gene therapy supports long-term reconstitution of patient hematopoietic stem cells in deficiency of adenosine deaminase 2Chiara Rigamonti, Dimitri Bulté, Federica Barzaghi, et al.Pageof 8